中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2009年
21期
60-61
,共2页
卡托普利%胺碘酮%老年高血压%心房颤动
卡託普利%胺碘酮%老年高血壓%心房顫動
잡탁보리%알전동%노년고혈압%심방전동
Captopril%Amiodarone%Elderly hypertensive%Paroxysmal atrial fibrillation
目的:观察卡托普利联合胺碘酮治疗老年高血压伴阵发性心房颤动(房颤)患者的疗效.方法:将70例老年高血压伴阵发性房颤患者随机分为胺碘酮组和联合用药组(卡托普利联合胺碘酮),治疗12个月,计算两组治疗后第3、6、9、12个月的窦性心律维持率和治疗前及治疗后第6、12个月的左心房内径.结果:研究期结束后各组内治疗前后血压变化比较具有显著性,但两组间治疗后血压无显著性差异.治疗后9、12个月,联合用药组的窦性心律维持率显著高于胺碘酮组.两组间左心房内径在治疗后12个月时胺碘酮组显著高于联合用药组.结论:卡托普利联合胺碘酮治疗老年高血压伴阵发性房颤,可抑制左房扩大,并有效预防房颤复发.
目的:觀察卡託普利聯閤胺碘酮治療老年高血壓伴陣髮性心房顫動(房顫)患者的療效.方法:將70例老年高血壓伴陣髮性房顫患者隨機分為胺碘酮組和聯閤用藥組(卡託普利聯閤胺碘酮),治療12箇月,計算兩組治療後第3、6、9、12箇月的竇性心律維持率和治療前及治療後第6、12箇月的左心房內徑.結果:研究期結束後各組內治療前後血壓變化比較具有顯著性,但兩組間治療後血壓無顯著性差異.治療後9、12箇月,聯閤用藥組的竇性心律維持率顯著高于胺碘酮組.兩組間左心房內徑在治療後12箇月時胺碘酮組顯著高于聯閤用藥組.結論:卡託普利聯閤胺碘酮治療老年高血壓伴陣髮性房顫,可抑製左房擴大,併有效預防房顫複髮.
목적:관찰잡탁보리연합알전동치료노년고혈압반진발성심방전동(방전)환자적료효.방법:장70례노년고혈압반진발성방전환자수궤분위알전동조화연합용약조(잡탁보리연합알전동),치료12개월,계산량조치료후제3、6、9、12개월적두성심률유지솔화치료전급치료후제6、12개월적좌심방내경.결과:연구기결속후각조내치료전후혈압변화비교구유현저성,단량조간치료후혈압무현저성차이.치료후9、12개월,연합용약조적두성심률유지솔현저고우알전동조.량조간좌심방내경재치료후12개월시알전동조현저고우연합용약조.결론:잡탁보리연합알전동치료노년고혈압반진발성방전,가억제좌방확대,병유효예방방전복발.
Objective: To evaluate the treatment of Captopril and Amiodarone to cure the elder hypertension and paroxysmal atrial fibrillation. Methods: 70 cases of elderly hypertensive patients with paroxysmal atrial fibrillation were randomly divided into Amiodarone group and combination group (Captopril combined Amiodarone), they were treated of 12 months, the rhythm control of the two groups after treatment 3, 6, 9,12 months and the left atrial diameter after treatment 6, 12 months were calculated. Results: There were significant changes of the blood pressure after treatment in each group, but no significant difference between two groups. The rate of rhythm control of the combination group was significant higher than that of the Amiodarone group after 9 and 12 months treatment. The change of the left atrial diameter was significant between the two groups after 12 months treatment. Conclusion: Captopfil combined with Amiodarone can decrease the blood pressure, inhibit left atrial enlargement and effective in preventing recurrence of atrial fibrillation in elderly hypertensive paroxysmal atrial fibrillation.